Purchase Order 36C25722P0340
Award Date 3/15/22
Potential Completion Date 3/14/27
Potential Value $257K
Federal Agency
Awardee
Ultimate Awardee
NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Antonio, TX 78229, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This $139,428.00 firm fixed price purchase order was awarded by the Defense Health Agency (DHA) to Biotheranostics Inc., a self-certified small disadvantaged business. The contract is for the provision of Biotheranostics' proprietary Breast Cancer Index genomic diagnostic testing services to support cancer care for the DHA's beneficiary population. This contract award represents one of several prime federal awards, totaling over $700,000 between 2021-2023, that Biotheranostics has received...
- The Defense Health Agency awarded a $139,428 firm fixed price purchase order to Biotheranostics Inc., a small disadvantaged business specializing in advanced molecular diagnostics and genomic testing services. The contract, which commenced on September 30, 2025 with an ultimate completion date of October 30, 2025, covers Breast Cancer Index (BCI) testing services to be performed at the Bethesda, Maryland location. This award represents a continuation of DHA's precision oncology efforts,...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Biotheranostics Inc., a self-certified small disadvantaged business, to provide Breast Cancer Index testing services for the Walter Reed National Military Medical Center. The $96,825 contract does not have a set-aside designation. Biotheranostics specializes in providing genomic diagnostic testing to support precision oncology and has been awarded multiple federal contracts by the Department of Veterans...
- Biotheranostics Inc., a small disadvantaged business and division of Hologic Inc., was awarded a $47.4K purchase order by Veterans Integrated Service Network 6 (VISN 6) for cancer identification testing services. The contract, issued on October 7, 2021, with an ultimate completion date of October 6, 2026, utilizes firm fixed-price pricing with no set-aside designation. Performance will occur in San Diego, California, where Biotheranostics maintains its headquarters and specializes in advanced...
- The U.S. Defense Health Agency (DHA) has awarded a $139,428 firm fixed price purchase order to Biotheranostics Inc., a self-certified small disadvantaged business, to provide Breast Cancer Index testing services. This award, with a completion date of September 25, 2024, is not set aside and supports the DHA's efforts to enhance cancer care for veterans and service members through advanced molecular diagnostics that guide treatment planning. Biotheranostics, a division of Hologic, Inc., has...
- This federal contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, is for the provision of the company's Oncotype DX portfolio of cancer diagnostic assays. The contract, valued at $200,327.28, was awarded by the Veterans Integrated Service Network 6 (VISN 6) of the U.S. Department of Veterans Affairs (VA). It is a firm-fixed-price purchase order with a period of performance through September 30, 2025. The contract does not utilize a set-aside designation, as Genomic...
- This is a firm fixed-price BPA call order awarded by the Department of Veterans Affairs (VA) to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation. The contract, valued at $3,453.96, is for the provision of express cancer testing services, specifically Oncotype DX assays, to support the VA's healthcare programs. Genomic Health, as a provider of genomic-based cancer diagnostic tests, has received numerous prime and subcontractor awards from various federal agencies, including the...
- This contract award to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, is for the provision of Oncotype genetic testing services to the U.S. Department of Veterans Affairs (VA) Veterans Integrated Service Network 22. The $114,305 Blanket Purchase Agreement (BPA) call covers a performance period through February 2026 and allows the VA to order cancer screening, treatment selection, and disease monitoring testing services on an as-needed basis. Genomic Health is also the prime...
- This is a firm fixed price Blanket Purchase Agreement (BPA) call awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 15 to Genomic Health, Inc., a subsidiary of Exact Sciences Corp, for their Oncotype DX cancer diagnostic services. The contract has a ceiling value of $3,453.96 and a period of performance through March 9, 2021. Genomic Health is a provider of genomic-based cancer testing services to federal agencies, including the VA, Department of Defense,...
- This is a firm fixed-price contract awarded by the Department of Veterans Affairs Veterans Health Administration to Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, for the provision of proprietary genetic testing services for cancer diagnosis and treatment selection. The contract was issued as a Blanket Purchase Agreement (BPA) call order under Genomic Health's existing General Services Administration (GSA) Medical Laboratory Testing and Analysis Services schedule contract. The...